Par Drugs & Chemicals Ltd

Financial Results

Par Drugs & Chemicals Q4 FY26 Results: Net Profit ₹13.1 Cr, Down 2.2% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹103.7 Cr (+2.7% YoY) and net profit of ₹13.1 Cr (-2.2% YoY) for Q4 FY26.

Key figure

Net profit ₹13.1 Cr · -2.2% YoY

Financial Results

Par Drugs & Chemicals Q1 FY27 Results: Net Profit ₹4.7 Cr, Up 42.4% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹31.3 Cr (+20.4% YoY) and net profit of ₹4.7 Cr (+42.4% YoY) for Q1 FY27.

Key figure

Net profit ₹4.7 Cr · +42.4% YoY

Financial Results

Par Drugs & Chemicals Q4 FY26 Results: Net Profit ₹0.9 Cr, Down 47.1% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹19.6 Cr (-12.1% YoY) and net profit of ₹0.9 Cr (-47.1% YoY) for Q4 FY26.

Key figure

Net profit ₹0.9 Cr · -47.1% YoY

Financial Results

Par Drugs & Chemicals Financial Results

Par Drugs and Chemicals Limited approved its FY2026 audited financial results and authorized a ₹90 Crore investment limit. The board also renewed its ₹1.61 Crore banking facility.